{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Springfield",
      "state": "PA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "64182",
      "recalling_firm": "Reumofan Plus USA",
      "address_1": "737 Buttonwood Dr.",
      "address_2": "N/A",
      "postal_code": "19064",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide through internet sales.",
      "recall_number": "D-837-2013",
      "product_description": "Reumofan Plus, 30-count tablets per bottle, distriubted by Reumofan Plus USA, LLC and Reumofan USA, LLC, Springfield, PA, and manufactured by Riger Natural S.A., Mexico.",
      "product_quantity": "586 bottles",
      "reason_for_recall": "Marketed without an approved NDA/ANDA: Product may contain undeclared active pharmaceutical ingredients Diclofenac Sodium, Dexamethasone, and Methocarbamol.",
      "recall_initiation_date": "20130104",
      "center_classification_date": "20130802",
      "termination_date": "20150129",
      "report_date": "20130814",
      "code_info": "Lot #: 99515, Exp 09/2016"
    }
  ]
}